A76: Long‐Term Efficacy of Canakinumab in Childhood Colchicine Resistant Familial Mediterranean Fever

Conclusion:This study demonstrated the longterm therapeutic effect of canakinumab in pediatric pts with CR‐FMF. AEs were manageable. Occasional increases in dose were needed while the dosing interval could be lengthened in some patients. A larger study is needed to better evaluate the benefit and optimal dosing of canakinumab for CR‐FMF.

Source: Arthritis and Rheumatism - March 27, 2014 Category: Rheumatology Authors: Philip Hashkes, Yonatan Butbul Aviel, Sari Lubin, Eliad Ben‐Dayan, Lillian Tseng, Riva Brik Tags: Poster Presentations Source Type: research